发明名称 INJECTABLE FORMULATION
摘要 <p>An object of the present invention is to provide a sustained-release injectable preparation which is in a medication administration form that can provide the effect of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one for a prolonged period of time, the preparation releasing a therapeutically effective amount of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one for at least one week. The present invention provides an injectable preparation containing 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof as an active ingredient, which releases the active ingredient in such a manner that its blood concentration is maintained for at least one week.</p>
申请公布号 EP2868318(A1) 申请公布日期 2015.05.06
申请号 EP20130781458 申请日期 2013.04.23
申请人 OTSUKA PHARMACEUTICAL CO., LIMITED 发明人 SATO, TETSUYA;MINOWA, TAKUYA;HOSHIKA, YUSUKE;TOYOFUKU, HIDEKAZU
分类号 A61K31/496;A61K9/00;A61K9/10;A61K47/02;A61K47/08;A61K47/18;A61K47/22;A61K47/26;A61K47/32;A61K47/34 主分类号 A61K31/496
代理机构 代理人
主权项
地址